Cytokinetics | Activos Circulantes



Current Assets Cambio Fecha
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Cytokinetics USD 1.11B 89.34M 2024-12
Eisai JPY 761.1B 79.19B 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Exelixis USD 1.47B 82.14M 2025-01
Geron USD 490.99M 92.94M 2024-12
Halozyme Therapeutics USD 1.09B 41.64M 2024-12
Intra Cellular Therapies USD 1.31B 35.63M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
Ligand Pharmaceuticals USD 331.56M 22.17M 2024-12
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06



Cytokinetics Activos Circulantes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.